These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2010307)

  • 1. Anti-CEA monoclonal antibody 99mTc-BW 431/26 in the diagnostic workup of patients with colorectal cancer.
    Fraile M; Buxeda M; Castell J; Torres M; Jimenez-Heffernan A; Mateo A; Soriano B; Doménech-Torné FM
    Int J Rad Appl Instrum B; 1991; 18(1):53-7. PubMed ID: 2010307
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
    Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
    Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
    Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
    Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody].
    Rilinger N; Niemann H; Halbfass HJ
    Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
    Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
    Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
    Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
    Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
    Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
    Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
    Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
    Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
    Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
    Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
    Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
    Fritzsche H
    Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study.
    Lechner P; Lind P; Binter G; Cesnik H
    Dis Colon Rectum; 1993 Oct; 36(10):930-5. PubMed ID: 8404384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
    Bock E; Becker W; Scheele J; Wolf F
    Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
    Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
    Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value].
    Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R
    Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tc-99m-labeled anti-CEA antibodies in intraoperative diagnosis of colorectal cancer].
    Lechner P; Lind P; Binter G
    Nuklearmedizin; 1995 Feb; 34(1):8-14. PubMed ID: 7724366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.